No Decision Yet On Fate Of EU ATMP: Which Way Next?
This article was originally published in Clinica
Executive Summary
More than two years after a review of the EU Advanced Therapy Medicinal Products Regulation (1394/2007) showed that the legislation was fraught with difficulties, the European Commission still must decide whether it will revise the regulation or adopt corrective measures in the absence of a legislative change.